Predictors of survival and recurrence after primary surgery for cervical metastasis of unknown primary

[1]  Y. Joo,et al.  Evolving Strategy for Surgical Management of Oral Cancer: Present and Future , 2019, Clinical and experimental otorhinolaryngology.

[2]  J. Roh,et al.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery , 2019, Clinical and experimental otorhinolaryngology.

[3]  B. Burkey,et al.  A matched comparison of human papillomavirus–induced squamous cancer of unknown primary with early oropharynx cancer , 2018, The Laryngoscope.

[4]  R. de Bree,et al.  Prognostic value of lymph node ratio in head and neck squamous cell carcinoma , 2018, Head & neck.

[5]  M. Wiesenfarth,et al.  Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor , 2018, International journal of cancer.

[6]  Soon-Hyun Ahn,et al.  Comparison of Treatment Outcomes for T3 Glottic Squamous Cell Carcinoma: A Meta-Analysis , 2018, Clinical and experimental otorhinolaryngology.

[7]  A. Ho,et al.  Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer , 2017, JAMA oncology.

[8]  M. Ge,et al.  Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma , 2017, Clinical and experimental otorhinolaryngology.

[9]  A. Ho,et al.  Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Brian O'Sullivan,et al.  Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[11]  L. Alemany,et al.  Human papillomavirus as prognostic marker with rising prevalence in neck squamous cell carcinoma of unknown primary: A retrospective multicentre study. , 2017, European journal of cancer.

[12]  J. Roh,et al.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery , 2017, Clinical and experimental otorhinolaryngology.

[13]  G. Tolstonog,et al.  Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis. , 2016, Oral oncology.

[14]  B. O'Sullivan,et al.  Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma , 2016, Head & neck.

[15]  W. Hara,et al.  Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Merlano,et al.  Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience , 2016, Clinical and experimental otorhinolaryngology.

[17]  G. Clark,et al.  Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. , 2016, Oral oncology.

[18]  Lea Schroeder,et al.  The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review , 2015, Clinical & Experimental Metastasis.

[19]  J. Ridge,et al.  Management of Squamous Cancer Metastatic to Cervical Nodes With an Unknown Primary Site. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Roh,et al.  Extranodal extension and thickness of metastatic lymph node as a significant prognostic marker of recurrence and survival in head and neck squamous cell carcinoma. , 2015, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.

[21]  J. Roh,et al.  Patterns and treatment of neck metastases in patients with salivary gland cancers , 2015, Journal of surgical oncology.

[22]  D. Flieder,et al.  p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary , 2014, Head & neck.

[23]  J. Roh,et al.  Prognostic Value of Metastatic Nodal Volume and Lymph Node Ratio in Patients with Cervical Lymph Node Metastases from an Unknown Primary Tumor , 2014, Oncology.

[24]  L. Murray,et al.  Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. , 2012, Oral oncology.

[25]  J. Roh,et al.  Human papillomavirus and p16 detection in cervical lymph node metastases from an unknown primary tumor. , 2012, Oral oncology.

[26]  T. Clauditz,et al.  HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome. , 2012, Oral oncology.

[27]  J. Roh,et al.  Prognostic Value of Lymph Node Density in Node-Positive Patients with Oral Squamous Cell Carcinoma , 2011, Annals of Surgical Oncology.

[28]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[29]  Jeong Hyun Lee,et al.  Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. , 2009, Oral oncology.

[30]  S. El-Mofty,et al.  Detection of human papillomavirus‐related squamous cell carcinoma cytologically and by in situ hybridization in fine‐needle aspiration biopsies of cervical metastasis , 2008, Cancer.

[31]  D. Hussey,et al.  Management of the unknown primary carcinoma: Long‐term follow‐up on a negative PET scan and negative panendoscopy , 2008, Head & neck.

[32]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[33]  J. Werner,et al.  Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. , 2006, European journal of cancer.

[34]  D. Mintzer,et al.  Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell cancer center of pennsylvania hospital. , 2004, The oncologist.

[35]  K. Shah,et al.  Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  J. Johansen,et al.  Implication of 18F‐Fluoro‐2‐Deoxy‐D‐Glucose Positron Emission Tomography on Management of Carcinoma of Unknown Primary in the Head and Neck: A Danish Cohort Study , 2002, The Laryngoscope.

[37]  M. Lehtinen,et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.

[38]  D. Eisele,et al.  Oncologic Rationale for Bilateral Tonsillectomy in Head and Neck Squamous Cell Carcinoma of Unknown Primary Source , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[39]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[40]  C. Compton,et al.  Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck , 2016 .

[41]  Mohammad H Rahbar,et al.  Multicollinearity in Regression Analyses Conducted in Epidemiologic Studies. , 2016, Epidemiology.